|
    ABT U.S.: NYSE

    Abbott Laboratories

    ABTUS
    After Hours
    Back To Top
    Last Updated: Jul 26, 2021 6:23 p.m. EDT Delayed quote

    $ 119.47

    0.00 -0.04%
    After Hours Volume: 515.38K
    Close Chg Chg %
    $119.52 -1.28 -1.06%
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 4.95M 65 Day Avg: 6.2M
    80% vs Avg
    118.38 Day Range 120.49
    98.41 52 Week Range 128.54

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABT Overview

    Performance

    5 Day
    • 0.61%
    1 Month
    • 3.30%
    3 Month
    • -2.50%
    YTD
    • 9.16%
    1 Year
    • 19.53%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 23 Full Ratings

    Recent News

    • eLesor
    • Dow Jones
    Read full story

    Abbott Laboratories stock underperforms Monday when compared to competitors

    Read full story

    Abbott Laboratories stock rises Friday, outperforms market

    Read full story

    Abbott Laboratories stock underperforms Thursday when compared to competitors

    Abbott Labs stock gains after profit more than doubles, sales rise above expectations

    Abbott Laboratories 2Q Sales Rise, Beat Analysts' Expectations

    Abbott Labs Q2 adj. EPS $1.17; FactSet consensus $1.02

    Abbott Labs Q2 sales $10.22 bln vs. $7.33 bln; FactSet consensus $9.69 bln

    Abbott Labs Q2 EPS 66 cents vs. 30 cents a year ago

    Read full story

    Abbott Laboratories stock rises Wednesday, still underperforms market

    Read full story

    Abbott Laboratories stock falls Tuesday, underperforms market

    Read full story

    Abbott Laboratories stock outperforms competitors on strong trading day

    Read full story

    Abbott Laboratories stock outperforms competitors on strong trading day

    Read full story

    Abbott Laboratories stock outperforms competitors despite losses on the day

    Read full story

    Abbott Laboratories stock underperforms Wednesday when compared to competitors

    Read full story

    Abbott Laboratories stock falls Tuesday, still outperforms market

    Read full story

    Abbott Laboratories stock falls Monday, underperforms market

    Read full story

    Abbott Laboratories stock rises Friday, still underperforms market

    Read full story

    Abbott Laboratories stock falls Thursday, still outperforms market

    Read full story

    Abbott Laboratories stock outperforms competitors on strong trading day

    Read full story

    Abbott Laboratories stock outperforms competitors on strong trading day

    • Other News
    • Press Releases

    The Smartest Dividend Aristocrats to Buy With $500 Right Now

    on Motley Fool

    Abbott’s Q2 Earnings Rise 105%, Beat Estimates

    on TipRanks.com

    Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Biogen (BIIB)

    on TipRanks.com

    The Next Nano-X, but With Less Risk?

    on Motley Fool

    Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript

    on Motley Fool

    Covid-19 Test Innovations Drawing New Interest from FDA and Consortiums

    on Baystreet.ca

    Abbott (ABT) Q2 Earnings Beat, Molecular Diagnostic Sales Drop

    on Zacks.com

    Abbott (ABT) Surpasses Q2 Earnings and Revenue Estimates

    on Zacks.com

    5 Hottest Earnings Charts This Week

    on Zacks.com

    Leerink Partners Keeps Their Hold Rating on Abbott Labs (ABT)

    on TipRanks.com

    Better Meme Stock: Clover Health or Senseonics Holdings?

    on Motley Fool

    Lower COVID-19 Testing Demand to Drag Abbott (ABT) Q2 Earnings

    on Zacks.com

    Abbott (ABT) Earnings Expected to Grow: Should You Buy?

    on Zacks.com

    Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

    on Zacks.com

    5 Stocks to Own for the Surge in Coronavirus Variants

    on Motley Fool

    5 “Strong Buy” Dividend Stocks for July 2021

    on TipRanks.com

    PAHC vs. ABT: Which Stock Should Value Investors Buy Now?

    on Zacks.com

    Why Lucira Health Is Rocketing Higher Today

    on Motley Fool

    7 Super-Safe Dividend Stock Performers to Buy

    on InvestorPlace.com

    Grab these 3 MedTech Stocks That Outperformed S&P 500 YTD

    on Zacks.com

    Abbott Laboratories

    Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson 0.05% $452.39B
    Roche Holding AG -0.79% CHF303.04B
    Roche Holding AG Akt -1.34% CHF303.04B
    Pfizer Inc. 0.31% $233.31B
    Novo Nordisk A/S Series B -1.73% kr.1.3T
    Merck & Co. Inc. -0.39% $196.34B
    Medtronic PLC -0.37% $172.75B
    AstraZeneca PLC -2.22% £131.37B
    AstraZeneca PLC ADR 0.21% $180.65B
    Siemens AG -0.10% €107.53B
    Competitor Data Provided ByCapital Cube Logo